Verrica Pharmaceuticals Inc (VRCA)
7.22
+0.17
(+2.41%)
USD |
NASDAQ |
Jun 27, 16:00
7.22
0.00 (0.00%)
After-Hours: 20:00
Verrica Pharmaceuticals Cash from Financing (Quarterly): -0.661M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -0.661M |
| December 31, 2023 | -0.027M |
| September 30, 2023 | 44.04M |
| June 30, 2023 | -0.084M |
| March 31, 2023 | 30.28M |
| December 31, 2022 | 0.00 |
| September 30, 2022 | -16.85M |
| June 30, 2022 | -0.001M |
| March 31, 2022 | -0.018M |
| December 31, 2021 | -0.003M |
| September 30, 2021 | 0.043M |
| June 30, 2021 | 0.241M |
| March 31, 2021 | 33.36M |
| December 31, 2020 | 0.445M |
| September 30, 2020 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2020 | -0.09M |
| March 31, 2020 | 34.88M |
| December 31, 2019 | 0.204M |
| September 30, 2019 | 0.004M |
| June 30, 2019 | 0.212M |
| March 31, 2019 | 0.003M |
| December 31, 2018 | 0.009M |
| September 30, 2018 | -1.064M |
| June 30, 2018 | 79.44M |
| March 31, 2018 | 20.99M |
| December 31, 2017 | 10.11M |
| September 30, 2017 | 0.965M |
| June 30, 2017 | 1.158M |
| March 31, 2017 | 0.482M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-16.85M
Minimum
Sep 2022
44.04M
Maximum
Sep 2023
6.299M
Average
0.002M
Median
Cash from Financing (Quarterly) Benchmarks
| Emergent BioSolutions Inc | 40.70M |
| Macrogenics Inc | 0.248M |
| Aquestive Therapeutics Inc | 81.74M |
| Recursion Pharmaceuticals Inc | 13.90M |
| Omega Therapeutics Inc | -1.07M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -19.95M |
| Free Cash Flow | -53.93M |
| Free Cash Flow Per Share (Quarterly) | -0.4291 |
| Free Cash Flow to Equity (Quarterly) | -19.92M |
| Free Cash Flow Yield | -16.17% |